Related Experiment Video
Updated: Jan 27, 2026

Immunofluorescence Analysis of Endogenous and Exogenous Centromere-kinetochore Proteins
Published on: March 3, 2016
Endogenous and Exogenous Stimuli-Responsive Drug Delivery Systems for Programmed Site-Specific Release
Ali Raza1, Tahir Rasheed2, Faran Nabeel3
1School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China. aliraza86@sjtu.edu.cn.
This review explores smart drug delivery systems (DDS) that respond to internal or external stimuli for targeted release. It highlights advancements and challenges in developing these responsive polymeric carriers for improved therapeutic outcomes.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Nanotechnology
Background:
- Conventional therapeutics face limitations in efficacy and side effects.
- Stimuli-responsive drug delivery systems (DDS) offer programmed, site-specific drug release.
- Smart DDS leverage endogenous and exogenous stimuli for enhanced therapeutic targeting.
Purpose of the Study:
- To review state-of-the-art endogenous and exogenous stimuli-responsive DDS.
- To focus on the chemistry and mechanisms of polymeric carriers for targeted release.
- To identify research gaps and challenges in stimuli-responsive DDS development.
Main Methods:
- Comprehensive literature review of stimuli-responsive DDS.
- Analysis of polymeric carriers responding to various stimuli (redox, pH, temperature, light, magnetic, ultrasound, electrical).
- Focus on extracellular and intracellular drug release mechanisms.
Main Results:
- Numerous DDS utilizing single or multiple stimuli have been developed.
- Polymeric carriers demonstrate potential for controlled dose loading, sustained release, and targeted permeability.
- Significant advancements exist, but challenges in clinical application remain.
Conclusions:
- Stimuli-responsive DDS represent a significant advancement in drug delivery.
- Further research is needed to address existing challenges for broader clinical adoption.
- Optimizing drug release mechanisms and carrier design is crucial for future therapeutic applications.
Related Concept Videos
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Drugs Affecting Neurotransmitter Release or Uptake
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

